Literature DB >> 32974464

A case report of Adult-onset Still's disease as a cause of severe mitral regurgitation.

Shabir Hussain Shah1, Muhammad Azam Shah1, Mohammad Shahbaz Khan1, Faisal Abdullah Alghamdi1.   

Abstract

BACKGROUND: Adult-onset Still's disease (AOSD) is an uncommon systemic inflammatory disease, causing spiking fever, skin rash, and arthritis. Pericarditis and myocarditis are the most common cardiac manifestation of AOSD but valvular involvement is rarely reported. CASE
SUMMARY: An 18-year-old boy presented with gradually worsening shortness of breath for 6 months. There was a history of low-grade intermittent fever and polyarthralgia affecting ankles, knees, and elbows. He was in heart failure with cardiogenic and septic shock. He was managed initially with antibiotics, inotropes, and diuretics. Echocardiography showed flail anterior mitral leaflet with severe mitral regurgitation. He remained febrile with persistent negative blood cultures. Intravenous antibiotics led to neutropenia without any response to fever and clinical status. On further workup, he was diagnosed to have AOSD, and he responded dramatically to oral steroid therapy. Later his mitral valve was replaced surgically. On follow-up, he was stable with mild exertional dyspnoea. His international normalized ratio was in therapeutic range and his follow-up echocardiography showed normally functioning mitral prosthesis. He is following rheumatology and currently on the maintenance dose of steroids. DISCUSSION: Adult-onset Still's disease is a systemic illness with diagnosis is based on clinical features and exclusion of other illnesses. Adult-onset Still's disease should be considered as a differential diagnosis in culture-negative endocarditis, especially in those with systemic features and non-responders to antibiotics.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.

Entities:  

Keywords:  Adult-onset Still’s disease; Case report; Infective endocarditis; Mitral regurgitation

Year:  2020        PMID: 32974464      PMCID: PMC7501920          DOI: 10.1093/ehjcr/ytaa127

Source DB:  PubMed          Journal:  Eur Heart J Case Rep        ISSN: 2514-2119


Adult-onset Still’s disease is systemic disease presenting as triad of fever, rash, and arthralgias. Cardiac manifestations range from pericarditis, myocarditis to endocarditis. Management of cardiac involvement depends on the severity. Adult-onset Still’s disease should be considered as differential diagnosis in culture-negative infective endocarditis.

Introduction

Adult-onset Still’s disease (AOSD) is an uncommon systemic inflammatory disease, causing spiking fever, skin rash, and arthritis. It is characterized by the presence of neutrophilic granulocytosis, raised ferritin levels, deranged liver enzymes, and absence of rheumatoid factor and antinuclear antibody test results., The exact aetiology of this illness is still unknown, and the diagnosis is based on exclusion, as there are no pathognomonic features. Pericarditis and myocarditis are the most common cardiac manifestation of AOSD, but valvular involvement is also reported., Here, we report a case of a young male who was initially diagnosed and treated as infective endocarditis, but later multisystemic involvement, lack of response to antibiotics, and further workup led to the diagnosis of AOSD. Admission with infective endocarditis and heart failure Diagnosed severe mitral regurgitation due to flail leaflet Intravenous diuretics Antibiotics Development of neutropenia Haemodynamically stable Negative blood cultures and positron emission tomography scan Antibiotics stopped Diagnosis of Adult-onset Still’s disease Recovery from neutropenia Started corticosteroid treatment Leucocytosis Symptomatic recovery Discharge home Elective admission for surgery after 8 weeks Surgical mitral valve replacement Post-operative recovery Discharge

Case presentation

An 18-year-old boy presented to our centre with gradually worsening shortness of breath for 6 months. For the last 5 days, he was experiencing dyspnoea at rest, along with orthopnoea and paroxysmal nocturnal dyspnoea. There was a history of low-grade intermittent fever and polyarthralgia affecting ankles, knees, and elbows. He also experienced intermittent ankle joint swelling over the past 2 months. His symptoms were associated with productive cough and a single episode of haemoptysis. On physical examination, he was tachycardic (heart rate of 105 b.p.m.) with low blood pressure (92/59 mm/Hg) and oxygen saturation was 89% on room air. His recorded body temperature was up to 39°C. Right supraclavicular lymph nodes were palpable. His apex beat was displaced and on auscultation, he had a pan-systolic murmur at the mitral area, radiating to the axilla. Initially, he presented to the secondary level hospital and diagnosed as infective endocarditis based on history and transthoracic echocardiographic finding of possible vegetation on the mitral valve (, Supplementary material online, Video 1). He was started on intravenous (IV) antibiotics (Vancomycin, Gentamycin, and Ceftriaxone) without significant response. He was admitted to the cardiac care unit after transfer to our centre and started on Norepinephrine 0.03 μg/kg/min initially and then titrated according to blood pressure. Furosemide IV infusion was started at 10 mg/h. His antibiotics regimen was revised, and he was given Vancomycin 1 g IV twice daily, Gentamycin 60 mg IV thrice daily, and Tazobactam–piperacillin 4.5 g IV 6 hourly.
Figure 1

Transthoracic echocardiogram (parasternal long-axis view), on left showing flail anterior mitral leaflet and on right, severe posteriorly directed jet of severe mitral regurgitation. AML, anterior mitral leaflet; MR, mitral regurgitation.

Transoesophageal echocardiography showed Flail anterior mitral leaflet (mainly A2 segment) due to rupture chordae with severe mitral regurgitation (, Supplementary material online, Video 2). There was no evidence of vegetation on the mitral valve. The left ventricle was severely dilated with normal systolic function (ejection fraction = 60%). The right ventricle was normal in size and function, and other valves were normal. His blood investigations revealed negative blood cultures and low white cell count with neutropenia in the first week (). He remained febrile despite being on antibiotics. All antibiotics were stopped, considering them as a possible cause of neutropenia. Bone marrow biopsy was done, which showed hypocellular bone marrow (cellularity of 40%) with trilineage haematopoiesis. There was no evidence of granuloma or malignancy. After stopping antibiotics, repeated blood cultures remained negative. His total white cell and neutrophil count started rising, and he continued to have a fever. His other investigations revealed the erythrocyte sedimentation rate (ESR) of 68 mm/h (normal range <15 mm/h) and C reactive protein (CRP) 9 mg/L (normal range <3.0 mg/L). His liver functions were deranged (alanine transaminase, aspartate transaminase, alkaline phosphatase) (). His ferritin level was 25 499.4 ng/mL (normal range 12–300 ng/mL). Other immune markers like antineutrophil cytoplasmic antibody, antinuclear antibody (ANA), and rheumatoid factor (RF) were negative. The viral panel was also negative. The infectious disease team advised doing a whole-body positron emission tomography scan, which failed to show any focus of inflammation.
Table 1

Blood investigations during first and second admission

ParametersNormal valuesFirst admission
Second admission
First weekSecond weekThird weekFourth weekFirst weekOperative daySecond weekAt discharge
White cell count (109/L)3.9–115.761.696.3220.2512.8410.9314.813.67
Absolute neutrophil count1.35–7.52.930.523.3115.856.2811.3610.85
Haemoglobin (g/dL)13.5–188.88.78.28.311.211.67.610.6
Platelet count (109/L)155–435481353498765534406147830
Serum creatinine (μmol/L)64–10488110796546563645
Blood urea (mmol/L)3–7.55.56.56.67.94.04.63.93.7
Total bilirubin (μmol/L)3–2014.411.29.75.64.94.619.07.9
 Alanine transaminase (U/L)0–551459216430018171637
Aspartate transaminase (U/L)0–553869516311132625
Alkaline phosphatase (U/L)89–3655031325537332548
Blood investigations during first and second admission Transthoracic echocardiogram (parasternal long-axis view), on left showing flail anterior mitral leaflet and on right, severe posteriorly directed jet of severe mitral regurgitation. AML, anterior mitral leaflet; MR, mitral regurgitation. Transoesophageal echocardiography (at 144°), on left side showing flail anterior mitral leaflet and on right, severe posteriorly directed jet of severe mitral regurgitation. AML, anterior mitral leaflet; MR, mitral regurgitation. Considering his presentation of polyarthralgia, fever, and lymphadenopathy, rheumatology was consulted, who, based on Yamaguchi’s criteria, labelled him as an AOSD (). He was started on prednisolone 1 mg/kg/day. He responded to steroid therapy, and his fever started settling along with markers of inflammation (white cell count, ESR, and CRP). After 4 weeks of this admission, he was discharged home with outpatient follow-up with rheumatologist and cardiac surgeon. He was electively readmitted for surgery after 8 weeks. The mitral valve was assessed intraoperatively and due to non-suitability for repair, it was replaced with a mechanical valve (ATS size 31) with total chordae preservation. The excised valve was sent for histopathological examination which showed areas of fibrosis and mild myxoid degeneration with no evidence of inflammation or vegetation ().
Table 2

Yamaguchi diagnostic criteria for Adult-onset of Still’s disease

Major criteriaMinor criteria
Fever >39°C for at least 1 weekSore throat or pharyngitis
Arthralgia or arthritis for >2 weeksLymphadenopathy
Non-pruritic salmon-pink coloured rash (usually over trunk or extremities while febrile)Hepatomegaly or Splenomegaly
Leucocytosis >10 000/mm3Abnormal liver function tests/aminotransferases
Neutrophils >80%Negative tests for antinuclear antibodies or rheumatoid factors
Exclusion criteriaAt least 5 criteria, including 2 major and no exclusion criteria
Absence of infection
Absence of malignant disease
Absence of inflammatory disease
Biopsy of mitral leaflet tissue showing fibrosis with myxoid changes. Yamaguchi diagnostic criteria for Adult-onset of Still’s disease On follow-up, he was stable with mild exertional dyspnoea. His international normalized ratio was in therapeutic range, and he was following the rheumatology clinic as well and he is kept on low dose steroids. His follow-up echocardiography showed normally functioning mitral prosthesis with left ventricular ejection fraction of 55%.

Discussion

Adult-onset Still’s a disease is a systemic disorder with no clear aetiology. It is rare, with a prevalence of 1.5 cases per 100 000–1 000 000 people. The disease is more prevalent in females than in males. Although it has been reported with bimodal age distribution, the disease commonly affects the younger population, with three-quarters of patients reported are between age 16 and 35 years., Exact aetiology is unknown but genetic, altered cytokines production and microbial aetiologies have been suggested in the literature., The most common clinical manifestations include the triad of a typical salmon-pink rash, high-spiking fever, and arthralgias or arthritis. Fever and joint involvement are present in most of the cases and skin rash can be found in up to 72% of cases., Adult-onset Still’s disease is also known for its systemic involvement which includes myalgias, hepato-splenomegaly, pleural effusion, renal and haematological complications.,, The diagnosis of AOSD is exclusively dependent on clinical manifestation due to the absence of diagnostic tests and serological markers. The Yamaguchi criteria are most widely recognized for the diagnosis of AOSD with a statistical endorsement with a sensitivity of 96.2% and a sensitivity of 92.1%. (). The diagnosis of AOSD is made if at least five features are positive, and two of them should be major diagnostic criteria. It is crucial to exclude infections, inflammation, and malignancy before applying them to make this diagnosis. Our patient fulfilled three major and two minor criteria which are fever, arthritis, leucocytosis, liver dysfunction, and negative RF and ANA factors. The other laboratory tests in AOSD show the picture of the inflammatory process and most commonly include elevated ESR, thrombocytopenia of >400 000, and elevated ferritin levels. Although elevated ferritin levels are the non-specific but five-fold rise of serum ferritin levels highly suggests AOSD. The patient described in this report showed high ESR, thrombocytopenia, and elevated ferritin levels, which further strengthen the diagnosis of AOSD. Cardiac involvement is not a unique feature of AOSD, and it ranges from pericarditis to myocarditis. Clinical presentation is variable from pericardial effusion to cardiac tamponade. Myocarditis can present as arrhythmias, heart failure, and even cardiogenic shock., It can rarely affect endocardium resulting in non-infective endocarditis and valvular regurgitations. Initial treatment of choice is non-steroidal anti-inflammatory drugs, and whenever required corticosteroids and immunosuppressive therapy can be utilized with good outcomes. Adult-onset Still’s disease carries an excellent prognosis with low mortality rates with a recurrence rate of up to 10% per year. The case we are reporting here is a young male, who was initially diagnosed as infective endocarditis due to suspected vegetation on the mitral valve along with severe mitral regurgitation. He was febrile with persistent negative blood cultures. Intravenous antibiotics led to neutropenia without any response to fever and clinical status. On further workup, he was diagnosed to have AOSD, and he responded dramatically to oral steroid therapy. Later his mitral valve was surgically replaced as it was flail anterior mitral leaflet, which is not suitable for repair. In summary, AOSD is a systemic illness with diagnosis is based on clinical features and exclusion of other illnesses. Adult-onset Still’s disease should be considered as a differential diagnosis in culture-negative endocarditis, especially in those with systemic features and non-responders to antibiotics.

Lead author biography

Dr Shabir Hussain Shah is a qualified Cardiovascular and Thoracic Surgeon since 2005 with more than 13 years’ experience (post-M.Ch./post-doctorate) in operative cardiovascular and thoracic surgery with keen interest in the areas of Research and Development. After finishing clinical fellowship in advanced adult cardiac surgery at Mazankowski Alberta Heart Institute (MAHI), University of Alberta, Canada, he joined King Fahad Medical City, Riyadh, Saudi Arabia. He is a Consultant Cardiovascular Surgeon and head of cardiovascular intensive care unit. He is also serving as programme director of cardiac surgery residency programme at the same centre.

Supplementary material

Supplementary material is available at European Heart Journal - Case Reports online. Slide sets: A fully edited slide set detailing this case and suitable for local presentation is available online as Supplementary data. Consent: The author/s confirm that written consent for submission and publication of this case report including image(s) and associated text has been obtained from the patient in line with COPE guidance. Conflict of interest: none declared. Click here for additional data file.
First admissionWeek 1

Admission with infective endocarditis and heart failure

Diagnosed severe mitral regurgitation due to flail leaflet

Intravenous diuretics

Antibiotics

Week 2

Development of neutropenia

Haemodynamically stable

Negative blood cultures and positron emission tomography scan

Antibiotics stopped

Week 3

Diagnosis of Adult-onset Still’s disease

Recovery from neutropenia

Started corticosteroid treatment

Week 4

Leucocytosis

Symptomatic recovery

Discharge home

Second admissionWeek 1

Elective admission for surgery after 8 weeks

Surgical mitral valve replacement

Week 2

Post-operative recovery

Discharge

  14 in total

1.  Adult Still's disease: a multicenter survey of Japanese patients.

Authors:  A Ohta; M Yamaguchi; T Tsunematsu; R Kasukawa; H Mizushima; H Kashiwagi; S Kashiwazaki; K Tanimoto; Y Matsumoto; M Akizuki
Journal:  J Rheumatol       Date:  1990-08       Impact factor: 4.666

Review 2.  Diagnosis and management of adult onset Still's disease.

Authors:  P Efthimiou; P K Paik; L Bielory
Journal:  Ann Rheum Dis       Date:  2005-10-11       Impact factor: 19.103

Review 3.  Adult-onset Still's disease.

Authors:  L B van de Putte; J M Wouters
Journal:  Baillieres Clin Rheumatol       Date:  1991-08

4.  Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases.

Authors:  J M Wouters; L B van de Putte
Journal:  Q J Med       Date:  1986-11

5.  Adult Still's disease--recognition of a clinical syndrome and recent experience.

Authors:  E B Larson
Journal:  West J Med       Date:  1985-05

6.  Adult Still's disease: manifestations, disease course, and outcome in 62 patients.

Authors:  J Pouchot; J S Sampalis; F Beaudet; S Carette; F Décary; M Salusinsky-Sternbach; R O Hill; A Gutkowski; M Harth; D Myhal
Journal:  Medicine (Baltimore)       Date:  1991-03       Impact factor: 1.889

Review 7.  Serum ferritin: Past, present and future.

Authors:  Wei Wang; Mary Ann Knovich; Lan G Coffman; Frank M Torti; Suzy V Torti
Journal:  Biochim Biophys Acta       Date:  2010-03-19

8.  [Cardiac complications in adult onset Still disease: from pericarditis to tamponade as manifestations].

Authors:  M H Drouot; E Hachulla; E Houvenagel; P Y Hatron; R M Flipo; L Goullard; G Ducloux; B Devulder
Journal:  Rev Med Interne       Date:  1994       Impact factor: 0.728

9.  Adult onset Still's disease as a cause of acute severe mitral and aortic regurgitation.

Authors:  Jae Seung Lee; Il No Do; Deok Hyun Kang; Seok Jung Joo; Bin Yoo; Hee Bom Moon; Chang-Keun Lee
Journal:  Korean J Intern Med       Date:  2005-09       Impact factor: 2.884

10.  Adult Onset Still's Disease: A Review on Diagnostic Workup and Treatment Options.

Authors:  Rajesh Gopalarathinam; Eric Orlowsky; Ramesh Kesavalu; Sreeteja Yelaminchili
Journal:  Case Rep Rheumatol       Date:  2016-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.